MTNB
Matinas Biopharma·AMEX
--
--(--)
--
--(--)
7.62 / 10
Outperform
Money flow analysis registers a strong 7.62/10, reflecting robust fund flow characteristics. Positive momentum in small and extra-large orders is offset by negative trends in overall, block, medium, and large flows. This implies institutional interest but also some caution, leading to a neutral-to-positive sentiment that complements the otherwise neutral technical and fundamental views.
Fund Flow Rating
What is the analyst consensus for MTNB?
- MTNB holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.62/10 (Outperform).
